New Drugs

Brand/Generic Company Description
Addyi
flibanserin
Sprout (U.S.)/Therapeutic Pro

A serotonin agonist/antagonist for premenopausal women with hypoactive sexual desire disorder.

Afluria Tetra
influenza vaccine
Seqirus

Quadrivalent influenza vaccine for preventing influenza.

Besponsa
inotuzumab ozogamicin
Pfizer

A CD22-directed antibody-drug conjugate for advanced B-cell precursor acute lymphoblastic leukemia.

Bevespi Aerosphere
glycopyrronium/formoterol
AstraZeneca

New LAMA/LABA combination inhaler for COPD.

Contrave
naltrexone/bupropion
Valeant

A combination opioid antagonist and antidepressant for weight management.

Cutaquig
immunoglobulin G
Octapharma

Human immunoglobulin given by SC infusion for primary or secondary immune deficiency.

Fasenra
benralizumab
Astra Zeneca

A monoclonal antibody for add-on maintenance treatment of severe eosinophilic asthma.

Kisqali
ribociclib
Novartis

A kinase inhibitor for postmenopausal women with advanced breast cancer.

Lapelga
pegfilgrastim
Apotex

First biosimilar to Neulasta.

Lonsurf
trifluridine/tipiracil
Taiho Pharma

New oral combination formulation for metastatic colorectal cancer.

Mezera
mesalazine
Avir Pharma

A rectal foam enema for ulcerative colitis and rectal suppository for ulcerative proctitis.

Mvasi
bevacizumab
Amgen

A biosimilar to Avastin, for colorectal & non-small cell lung cancer.

Ozempic
semaglutide
Novo Nordisk

A GLP-1 agonist for type 2 diabetes.

Penthrox
methoxyflurane
Purdue Pharma

A self-administered inhaled anesthetic/analgesic for short-term relief of moderate to severe acute pain.

Rekovelle
follitropin delta
Ferring

A recombinant human FSH for ovarian stimulation.

Siliq
brodalumab
Valeant

An IL-17RA blocker for moderate to severe plaque psoriasis.

Symtuza
darunavir/cobicistat/emtricitabine/ tenofovir alafenamide
Janssen

New combination regimen for HIV-1 infection.

Trelegy Ellipta
fluticasone furoate/umeclidinium/vilanterol
GSK

A new combination oral inhaler for COPD.

Velphoro
sucroferric oxyhydroxide
Vifor Fresenius/Innomar Strate

A chewable, calcium-free phosphate binder.

Brand/Generic Company Description
Arbesda
fluticasone/salmeterol
Teva

A steroid/LABA combination oral inhaler for asthma.

Bevespi Aerosphere
glycopyrronium/formoterol
AstraZeneca

New LAMA/LABA combination inhaler for COPD.

Contrave
naltrexone/bupropion
Valeant

A combination opioid antagonist and antidepressant for weight management.

Fucibet
betamethasone/fusidic acid
Leo Pharma

An antibiotic/steroid topical cream for eczema.

Mezera
mesalazine
Avir Pharma

A rectal foam enema for ulcerative colitis and rectal suppository for ulcerative proctitis.

Probuphine
buprenorphine
Knight Therapeutics

A partial opioid agonist subdermal implant for management of opioid dependence.

Symtuza
darunavir/cobicistat/emtricitabine/tenofovir alafenamide Janssen
Janssen

New combination regimen for HIV-1 infection.

Trelegy Ellipta
fluticasone furoate/umeclidinium/vilanterol
GSK

A new combination oral inhaler for COPD.

Xultophy
insulin degludec/liraglutide
Novo Nordisk

A combination long-acting insulin and GLP-1 agonist for type 2 diabetes.

Zinbryta
daclizumab
Biogen

Voluntary withdrawal due to safety concerns, including reports of severe liver damage and immune-related conditions.

Brand/Generic Company Description
Zinbryta
daclizumab
Biogen

Voluntary withdrawal due to safety concerns, including reports of severe liver damage and immune-related conditions.